대한방사선치료학회지 (The Journal of Korean Society for Radiation Therapy)

대한방사선치료학회 (Korean Society for Radiation Therapy)
권호 표지

호흡연동 용적변조 회전방사선치료에서 호흡주기에 따른 선량전달 정확성 검증

Dose verification for Gated Volumetric Modulated Arc Therapy according to Respiratory period

  • 전수동 (서울아산병원 방사선종양학과) ;
  • 배선명 (서울아산병원 방사선종양학과) ;
  • 윤인하 (서울아산병원 방사선종양학과) ;
  • 강태영 (서울아산병원 방사선종양학과) ;
  • 백금문 (서울아산병원 방사선종양학과)
  • Jeon, Soo Dong (Department of Radiation Oncology, ASAN Medical Center) ;
  • Bae, Sun Myung (Department of Radiation Oncology, ASAN Medical Center) ;
  • Yoon, In Ha (Department of Radiation Oncology, ASAN Medical Center) ;
  • Kang, Tae Young (Department of Radiation Oncology, ASAN Medical Center) ;
  • Baek, Geum Mun (Department of Radiation Oncology, ASAN Medical Center)
  • 투고 : 2014.04.09
  • 심사 : 2014.05.02
  • 발행 : 2014.06.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

목 적 : 호흡연동 용적변조 회전방사선치료(Gated Volumetric Modulated Arc Therapy)에서 환자의 호흡주기 변화에 따른 선량전달의 정확성을 검증하고자 한다. 대상 및 방법 : 실험에는 TrueBeam STxTM(Varian Medical Systems, Palo Alto, CA)치료기를 사용하였다. 인체모형등가팬텀(Rando Phantom, Alderson Resarch Laboratories Inc. Stamford. CT, USA)의 전산화단층영상에 전산화치료계획시스템(Eclipse 10.0, Varian, USA)을 이용하여 10 MV FFF(Flatenning Filter Free), 선량률 1200 MU/min으로 1500 cGy/fx(Case1, 2, 3)과 220 cGy/fx(Case4, 5, 6)의 치료계획을 수립하였다. $QUASAR^{TM}$ Respiratory Motion Phantom(Modus Medical Devices Inc)을 이용하여 1.5, 2.5, 3.5, 4.5 sec의 일정한 호흡주기와 평균호흡주기가 2.2, 3.5 sec인 환자의 호흡주기를 재현하였고 위상모드 30~70% 구간에서 방사선이 조사되도록 설정하였다. 각각의 호흡 조건에서 2차원 이온전리함 배열 검출기(I'mRT Matrixx, IBA Dosimetry, Germany)와 MultiCube Phantom(IBA Dosimetry, Germany)을 이용하여 측정하였고 세기변조 방사선치료 분석 프로그램(OmniPro I'mRT, IBA Dosimetry, Germany)을 이용하여 Gamma pass rate(3 mm, 3%)을 비교하였다. 결 과 : Case 1, 2, 3, 4, 5, 6의 Gamma pass rate은 일정한 호흡주기 1.5 sec에서 100.0, 97.6, 98.1, 96.3, 93.0, 94.8%, 2.5 sec에서 98.8, 99.5, 97.5, 99.5, 98.3, 99.6%, 3.5 sec에서 99.6, 96.6, 97.5, 99.2, 97.8, 99.1%, 4.5 sec에서 99.4, 96.3, 97.2, 99.0, 98.0, 99.3%의 결과를 보였다. 환자의 호흡을 재현한 경우 평균 호흡주기 2.2 sec에서는 97.7, 95.4, 96.2, 98.9, 96.2, 98.4%, 3.5 sec에서는 97.3, 97.5, 96.8, 100.0, 99.3 99.8%의 결과를 보였다. 결 론 : 2.5 sec이상의 일정한 호흡주기와 환자의 호흡을 재현한 실험에서 Gamma pass rate 95%이상의 임상적으로 신뢰할 만한 결과를 보였다. 일정한 호흡주기 1.5 sec의 Case 5, 6 에서 93.0, 94.8%의 결과를 보였으나 100명의 환자 호흡주기 분석 결과 1.5 sec의 호흡을 지속했던 경우는 없었던 점으로 보아 대부분의 호흡조건에서 정확한 선량전달이 가능함을 확인 하였다. 다만 극히 짧은 호흡주기로 인한 오차발생 가능성을 배제할 수 없기 때문에 치료전 선량전달 정확성 검증이 선행되어야 하며 모의치료시 환자 교육으로 안정된 호흡을 유지하고 정확한 모니터링을 통해 치료중 환자 호흡변화에 대처한다면 더욱 안정적이고 정확한 치료가 이루어질 것으로 사료된다.

Purpose : The purpose of this study is to verify the accuracy of dose delivery according to the patient's breathing cycle in Gated Volumetric Modulated Arc Therapy Materials and Methods : TrueBeam STxTM(Varian Medical System, Palo Alto, CA) was used in this experiment. The Computed tomography(CT) images that were acquired with RANDO Phantom(Alderson Research Laboratories Inc. Stamford. CT, USA), using Computerized treatment planning system(Eclipse 10.0, Varian, USA), were used to create VMAT plans using 10MV FFF with 1500 cGy/fx (case 1, 2, 3) and 220 cGy/fx(case 4, 5, 6) of doserate of 1200 MU/min. The regular respiratory period of 1.5, 2.5, 3.5 and 4.5 sec and the patients respiratory period of 2.2 and 3.5 sec were reproduced with the $QUASAR^{TM}$ Respiratory Motion Phantom(Modus Medical Devices Inc), and it was set up to deliver radiation at the phase mode between the ranges of 30 to 70%. The results were measured at respective respiratory conditions by a 2-Dimensional ion chamber array detector(I'mRT Matrixx, IBA Dosimetry, Germany) and a MultiCube Phantom(IBA Dosimetry, Germany), and the Gamma pass rate(3 mm, 3%) were compared by the IMRT analysis program(OmniPro I'mRT system software Version 1.7b, IBA Dosimetry, Germany) Results : The gamma pass rates of Case 1, 2, 3, 4, 5 and 6 were the results of 100.0, 97.6, 98.1, 96.3, 93.0, 94.8% at a regular respiratory period of 1.5 sec and 98.8, 99.5, 97.5, 99.5, 98.3, 99.6% at 2.5 sec, 99.6, 96.6, 97.5, 99.2, 97.8, 99.1% at 3.5 sec and 99.4, 96.3, 97.2, 99.0, 98.0, 99.3% at 4.5 sec, respectively. When a patient's respiration was reproduced, 97.7, 95.4, 96.2, 98.9, 96.2, 98.4% at average respiratory period of 2.2 sec, and 97.3, 97.5, 96.8, 100.0, 99.3, 99.8% at 3.5 sec, respectively. Conclusion : The experiment showed clinically reliable results of a Gamma pass rate of 95% or more when 2.5 sec or more of a regular breathing period and the patient's breathing were reproduced. While it showed the results of 93.0% and 94.8% at a regular breathing period of 1.5 sec of Case 5 and 6, it could be confirmed that the accurate dose delivery could be possible on the most respiratory conditions because based on the results of 100 patients's respiratory period analysis as no one sustained a respiration of 1.5 sec. But, pretreatment dose verification should be precede because we can't exclude the possibility of error occurrence due to extremely short respiratory period, also a training at the simulation and careful monitoring are necessary for a patient to maintain stable breathing. Consequently, more reliable and accurate treatments can be administered.

키워드

참고문헌

  1. Yen-Cho Huang, M.Sc, Chien-Yi Yeh at al.: Clinical practice and evaluation of electronic portal imaging device for VMAT. Medical Dosimetry 2013;38:35-41 https://doi.org/10.1016/j.meddos.2012.05.004
  2. Anton Mans, Peter Remeijer, Igor Olaciregui-Ruiz at al.: 3D Dosimetric Verification of volumetric modulated arc therapy by portal dosimetry. Radiotherapy and Oncology 2010;94:181-187 https://doi.org/10.1016/j.radonc.2009.12.020
  3. Stine Korreman, Joakim Medin, Flemming Kjær- Kristoffersen: Dosimetric verification of RapidArc treatment delivery. Acta Oncologica 2009;48:185-191 https://doi.org/10.1080/02841860802287116
  4. Bedford JL, Warrington AP: Commissioning of volumetric modulated arc therapy (VMAT). Int J Radiat Oncol Biol Phys 2009 Feb 1;73(2):537-45
  5. Jiwon Sung, Myonggeun Yoon, Weon Kuu Chung at al.: Evaluation of the Accuracy for Respiratory-gated RapidArc. PROGRESS in MEDICAL PHYSICS 2013;June;2;24
  6. Ruijiang Li, Edward Mok, Bin Han at al.: Evaluation of the geometric accuracy of surrogate-based gated VMAT using intrafraction kilovoltage x-ray images. Medical Physics 2012;39(5):2686-2693 https://doi.org/10.1118/1.4704729
  7. Jiango Qian, Lei Xing, Wu Liu, et al.: Dose verification for respiratory-gated volumetric modulated arc therapy. Physics In Medicine And Biology 2011;56:4827-4838 https://doi.org/10.1088/0031-9155/56/15/013
  8. Giorgia Nicolini, Eugenio Vanetti, Alessandro Clivio at al.: Pre-clinical evaluation of respiratory-gated delivery of volumetric modulated arc therapy with RapidArc. Physics In Medicine And Biology 2010;55:347-357 https://doi.org/10.1088/0031-9155/55/12/N01
  9. Ramesh Boggula, Mattias Birkner, Frank Lohr, et al.: Evaluation of a 2D detector array for patient-specific VMAT QA with different setups. Physics In Medicine And Biology 2011;56: 7163-7177 https://doi.org/10.1088/0031-9155/56/22/011
  10. Varatharaj Chandraraj, Sotririos Stathakis, Ravikumar Manickam et al.: Comparison of four commercial devices for RapidArc and sliding window IMRT QA. Journal of Applied Clinical Medical Physics 2011;12:338-349
  11. M.Stasi, S. Bresciani, A. Miranti at al.: Pretreatment patientspecific IMRT quality assurance: a correlation study between gamma index and patient clinical dose volume histogram. Medical Physics 2012;Dec;39(12):7626-34 https://doi.org/10.1118/1.4767763
  12. Francisco CH, Silvia VC: A Probability Approach to the Study on Uncertainty Effects on Gamma Index Evaluations in Radiation Therapy. Computational and Mathematical Methods in Medicine 2011; 861869:10
  13. Krishna Murthy K: Patient-specific quality assurance of RapidArc treatments: Portal prediction dosimetry compared with phantom studies. Biomedical Imaging and Intervention Journal 2012;8(4):e28
  14. Eduard Schreibmann, Anees Dhabaan, Eric Elder at al.: Patient-specific quality assurance method for VMAT treatment delivery. Medical Physics 2009;Oct;36:4530 https://doi.org/10.1118/1.3213085
  15. Giorgia Nicolini, Eugenio Vanetti, Alessandro Clivio at al.: The GLAaS algorithm for portal dosimetry and quality assurance of RapidArc, an intensity modulated rotational therapy. Radiation Oncology 2008;3:24 https://doi.org/10.1186/1748-717X-3-24